The drop on Friday was fear of how they were gonna come up with $50 million not to mention whatever the value of Canary Controlling Interest will be. I still think the share price will rise organically now that this news has had a chance to sink in and people are beginning to see the path forward and the caliber of the players involved. We’ve been one of the most posted boards this weekend if that gives us a sense of how big this news is. Once the pps averages 15 cents, which I honestly don’t expect to be too much longer, Koos could use the remaining authorized shares which at that price would equate to $50M, but it’s now seeming more likely that there is a large player behind the scenes that will enable that transaction. As someone posted on this board, there was an approximate amount of $50 million worth of shares sold by Eli Lilly recently earlier this month coincidently and the initial down payment for the Curevac deal was also $50 Million. Things that make you go hmmm… So it seems to me that RGBP will just be on the hook, initially anyway, for the common shares that represent Canary Controlling Interest and the $1,000,000. So how much is CCI gonna be worth is the question and will RGBP have enough authorized commons to complete the transaction? I guess it all depends on what the share price will be. With the upcoming catalysts, I suspect we will need far less commons than what we would need at this share pride. Just my opinion though. Getting extremely interesting around here to say the least. Go RGBP!! :-)
News 
Market Data 
Discover 
